Leaders say artificial intelligence can speed infection diagnosis, track outbreaks, and ease staffing strains—but adoption will roll out in stages.
At a national meeting of clinical microbiology leaders, scientists and industry partners mapped out how artificial intelligence (AI) is poised to change day‑to‑day lab work—from reading Petri dishes to predicting antibiotic resistance. The “Lab of the Future” discussions, hosted by the American Society for Microbiology’s Clinical Microbiology Open (CMO) in early 2024, brought together 56 participants and are summarized in a new Journal of Clinical Microbiology report.
What AI can do now (and soon)
Participants highlighted image‑analysis tools that can flag bacteria on culture plates, review Gram stains, and help spot parasites in blood and stool samples—jobs that traditionally require painstaking human review. Validated systems paired with chromogenic media have already shown high accuracy for organisms such as MRSA and VRE, and convolutional neural‑network models for intestinal protozoa topped 98% agreement with expert review, according to studies featured in the proceedings (see Table 2, “AI in clinical microbiology presentations”).
The report also explains why these newer “adaptive” systems differ from today’s rule‑based instruments: instead of following fixed rules, machine‑learning models learn patterns from large tables of lab data and images, improving as data grow. That opens the door to tasks like automatically measuring antibiotic susceptibility zones or clustering resistance patterns across thousands of isolates.
Smarter antibiotic choices
Beyond images, whole‑genome sequencing combined with machine learning is starting to predict whether a bug will resist certain drugs. Early studies cited by the group reported ~97% categorical agreement for cefepime susceptibility in E. coli and ~95% accuracy predicting minimum inhibitory concentrations across 15 antibiotics in Salmonella—encouraging signs for faster, targeted therapy.
Faster outbreak detection—and a heads‑up for high‑risk patients
By blending genomic data with electronic medical records, labs can spot transmission clusters earlier and guide infection‑prevention teams. One example discussed: in an ICU cohort, 7.4% of patients silently carried toxigenic C. difficile, and those carriers had a 9.3‑fold higher risk of developing infection and a 67% higher mortality than non‑carriers—signals AI could surface in time to intervene.
Adoption timeline: enthusiasm with guardrails
A live poll at the meeting captured measured optimism. Sixty‑two percent of respondents said AI is underrated in clinical microbiology. Near‑term wins are expected in image analysis (routine microscopy and culture‑plate interpretation) and quality monitoring. About one‑third expected to start using image analysis or quality‑monitoring AI by 2024‑25; however, roughly 29–35% anticipated broader adoption only after 2027—citing costs, staffing, and integration work. (Table 4, audience survey.)
The authors also flag the biggest hurdles labs face: limited in‑house AI expertise, the need to maintain and recalibrate models as data change, and an unsettled regulatory pathway. Bottom line: AI won’t replace clinical microbiologists, but it can help them work faster, standardize quality checks, and focus expertise where it matters most.
Why it matters for patients
- Quicker answers: AI that screens plates and slides can triage what needs a human expert right now, potentially shortening time to the right treatment.
- Better antibiotic picks: Genome‑plus‑ML tools could forecast resistance sooner, reducing trial‑and‑error prescribing.
- Stronger infection control: Combining lab and hospital data can spotlight hidden outbreaks and protect vulnerable patients.
What’s next
Expect incremental rollouts: image analysis and quality‑monitoring pilots first, followed by broader decision‑support as evidence and regulatory guidance firm up. Labs will still set the rules, but increasingly with AI at their elbow.
Source: “Proceedings of the Clinical Microbiology Open 2024: artificial intelligence applications in clinical microbiology,” Journal of Clinical Microbiology (April 2025).
Editor’s note: This article is for information only and is not a substitute for professional medical advice.